ON THIS PAGE: You will find information about how many people are diagnosed with a STS each year. You will also learn some general information on surviving the disease. Remember, survival rates depend on several factors. To see other pages, use the menu.
Overall, sarcoma is uncommon. This year, approximately 12,310 people (6,980 men and boys and 5,330 women and girls) will be diagnosed with STS in the United States.
An estimated 4,990 people (2,680 men and boys and 2,310 women and girls) are expected to die of the disease this year.
The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rates for people with STS are grouped based on the stage, or extent , of the sarcoma. The statistics below include different types of STS, but do not include Kaposi sarcoma .
The 5-year survival rate for people with STS that is only in the area it started is 83%. About 56% of patients are diagnosed at this early stage. If the sarcoma has spread to the nearby lymph nodes or regional tissue, the 5-year survival rate is 56%. If the sarcoma has spread to another area of the body, the 5-year survival rate is 16%. Survival rates also depend on other factors, including the specific type of STS diagnosed. Talk with your doctor about what to expect with your specific diagnosis.
It is important to remember that statistics on this type of cancer are an estimate. The estimate comes from data based on thousands of people with STS in the United States. So, your own risk may be different. Doctors cannot say for sure how long anyone will live with STS. Learn more about understanding statistics .
Statistics adapted from the American Cancer Society's publication, Cancer Facts and Figures 2016, and the National Cancer Institute.
The next section in this guide is Risk Factors . It explains what factors may increase the chance of developing this disease and what may lower your risk. Or, use the menu to choose another section to continue reading this guide.